[Mode of actions and mechanisms of resistance of new quinolones in Pseudomonas aeruginosa].
Hirai
K
K
Central Research Laboratories, Kyorin Pharmaceutical Co. Ltd.
Hashimoto
H
H
D002463:Cell Membrane Permeability; D004261:DNA Replication / Q000187:drug effects; D004250:DNA Topoisomerases, Type II / Q000235:genetics; D004269:DNA, Bacterial / Q000096:biosynthesis; D004352:Drug Resistance, Microbial / Q000235:genetics; D009154:Mutation; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000235:genetics; D015363:Quinolones / Q000494:pharmacology*; D059005:Topoisomerase II Inhibitors
D004269:DNA, Bacterial; D015363:Quinolones; D059005:Topoisomerase II Inhibitors; D004250:DNA Topoisomerases, Type II